ResearcherColumbia UniversityActive in the last 2 years
Amanda R. Decker-Farrell
Matched on ORCID iD 0000-0001-9969-7909; OpenAlex author ID A5078633014; NIH RePORTER profile ID 15166047. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 0)
- Trials
- 0
- Grants
- 1
- Labs led
- 0
- Collaborators
- 11
2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper, 1 grant · 2023: 1 paper · 2024: 4 papers
Papers 7
- Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer. Co-author DOI 10.1038/s41586-024-07379-z↗
- Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer. Co-author DOI 10.1038/s41586-024-08084-7↗
- “Tumor-selective treatment of metastatic pancreatic cancer with an engineered, probiotic living drug” Co-author DOI 10.1101/2024.05.02.592216↗
- Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression. First author DOI 10.1158/2159-8290.cd-23-0240↗
- Generation and ex vivo culture of murine and human pancreatic ductal adenocarcinoma tissue slice explants. Co-author DOI 10.1016/j.xpro.2023.102711↗
- Generation of orthotopic patient-derived xenograft models for pancreatic cancer using tumor slices. First author DOI 10.1016/j.xpro.2022.101899↗
- Effective Delivery of a Microtubule Polymerization Inhibitor Synergizes with Standard Regimens in Models of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-18-3281↗
Grants 1
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kenneth P. Olive · 5 shared papers, 2019–2024 · strength 0.93
- Paper Generation and ex vivo culture of murine and human pancreatic ductal adenocarcinoma tissue slice explants. DOI 10.1016/j.xpro.2023.102711↗
- Paper Generation of orthotopic patient-derived xenograft models for pancreatic cancer using tumor slices. DOI 10.1016/j.xpro.2022.101899↗
- Paper “Tumor-selective treatment of metastatic pancreatic cancer with an engineered, probiotic living drug” DOI 10.1101/2024.05.02.592216↗
- Alexander Muir · 2 shared papers, 2023–2024 · strength 0.40
- Paper Generation and ex vivo culture of murine and human pancreatic ductal adenocarcinoma tissue slice explants. DOI 10.1016/j.xpro.2023.102711↗
- Paper Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression. DOI 10.1158/2159-8290.cd-23-0240↗
- Álvaro Curiel‐García · 2 shared papers, 2022–2024 · strength 0.39
- Marie C. Hasselluhn · 2 shared papers, 2024 · strength 0.38
- H. Carlo Maurer · 2 shared papers, 2019–2024 · strength 0.25
- Paper Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression. DOI 10.1158/2159-8290.cd-23-0240↗
- Paper Effective Delivery of a Microtubule Polymerization Inhibitor Synergizes with Standard Regimens in Models of Pancreatic … DOI 10.1158/1078-0432.ccr-18-3281↗
- Michael A. Badgley · 1 shared paper, 2024 · strength 0.22
- Ezequiel J. Tolosa · 1 shared paper, 2024 · strength 0.17
- Andrea Califano · 1 shared paper, 2024 · strength 0.17
- Urszula N. Wasko · 1 shared paper, 2024 · strength 0.17
- Martín E. Fernández-Zapico · 1 shared paper, 2024 · strength 0.17
- Jaime A. Eberle-Singh · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.